Synaps

Developing novel photodynamic therapies for neurosurgery

Synaps
  • About
    • Overview
    • Partnership >
      • Onco-THAI Inserm U1189
      • University of Lille
      • Lille University Hospital
      • Inserm
      • ECRIN
      • Leitat Technological Center
      • IDDI
      • Medical University of Graz
      • OP2
      • Erasme Hospital
  • Research
    • Overview
    • Clinical trial
    • Publications
  • Medical information
    • Overview
    • Glioblastoma
    • PhotoDynamic Therapies
  • News
  • Contact

  • About
    • Overview
    • Partnership >
      • Onco-THAI Inserm U1189
      • University of Lille
      • Lille University Hospital
      • Inserm
      • ECRIN
      • Leitat Technological Center
      • IDDI
      • Medical University of Graz
      • OP2
      • Erasme Hospital
  • Research
    • Overview
    • Clinical trial
    • Publications
  • Medical information
    • Overview
    • Glioblastoma
    • PhotoDynamic Therapies
  • News
  • Contact

News

Synaps will be presented during the next H2020 European Health/Rare Diseases Brokerage Event – Oslo 2016

5/7/2016

 
During this event, Synaps will be introduced to new potential partners. The event is organized by the Research Council of Norway, the French Institutes / Embassies in the Nordic countries and the French Norwegian Foundation  and held in Oslo. This Horizon 2020 Health Brokerage Event will focus on rare diseases. Glioblastoma being a neoplastic rare disease, GBM photodynamic therapies will be presented with the aim to strengthen our team with new academic and industrial partnerships.
​More info on the event web site.
Picture
Facebook LinkedIn Twitter

Comments are closed.
Université Lille 2
Onco Thai
Inserm
CHRU Lille
Picture
 Legal notice - Credits